ClinVar Genomic variation as it relates to human health
NM_015713.5(RRM2B):c.979C>T (p.Arg327Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_015713.5(RRM2B):c.979C>T (p.Arg327Ter)
Variation ID: 5391 Accession: VCV000005391.12
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 8q22.3 8: 102208210 (GRCh38) [ NCBI UCSC ] 8: 103220438 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 24, 2015 Feb 14, 2024 Dec 26, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_015713.5:c.979C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_056528.2:p.Arg327Ter nonsense NM_001172477.1:c.1195C>T NP_001165948.1:p.Arg399Ter nonsense NM_001172478.2:c.823C>T NP_001165949.1:p.Arg275Ter nonsense NC_000008.11:g.102208210G>A NC_000008.10:g.103220438G>A NG_016617.1:g.35909C>T LRG_788:g.35909C>T LRG_788t1:c.1195C>T LRG_788p1:p.Arg399Ter LRG_788t2:c.979C>T LRG_788p2:p.Arg327Ter - Protein change
- R399*, R275*
- Other names
-
R327*
p.R327*:CGA>TGA
- Canonical SPDI
- NC_000008.11:102208209:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
RRM2B | - | - |
GRCh38 GRCh37 |
334 | 414 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, single submitter
|
Feb 23, 2023 | RCV000005722.14 | |
not provided (1) |
no classification provided
|
- | RCV000119016.12 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Dec 26, 2023 | RCV000197531.16 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Feb 23, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5
Affected status: yes
Allele origin:
unknown
|
3billion
Accession: SCV003841614.1
First in ClinVar: Mar 18, 2023 Last updated: Mar 18, 2023 |
Comment:
The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function … (more)
The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by less than 10%. The variant has been reported to co-segregate with the disease in at least 7 similarly affected relatives/individuals in at least two unrelated families (PMID: 19664747). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000005391 / PMID: 19664747). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Bilateral ptosis (present) , Autoimmune thrombocytopenia (present) , Abnormal circulating lipid concentration (present) , Ophthalmoplegia (present)
|
|
Pathogenic
(Dec 26, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003440810.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Arg327*) in the RRM2B gene. While this is not anticipated to result in nonsense mediated decay, … (more)
This sequence change creates a premature translational stop signal (p.Arg327*) in the RRM2B gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 25 amino acid(s) of the RRM2B protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with autosomal dominant progressive external ophthalmoplegia (PMID: 19664747, 23107649). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5391). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Oct 17, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000252197.14
First in ClinVar: Oct 11, 2015 Last updated: Apr 17, 2019 |
Comment:
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 25 amino acids are lost, and other loss-of-function variants have been … (more)
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 25 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23107649, 19664747, 33144682) (less)
|
|
Pathogenic
(Aug 01, 2009)
|
no assertion criteria provided
Method: literature only
|
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000025904.3
First in ClinVar: Apr 04, 2013 Last updated: Jan 02, 2021 |
Comment on evidence:
In affected members of 2 unrelated families with autosomal dominant progressive external ophthalmoplegia-5 (PEOA5; 613077), Tyynismaa et al. (2009) identified a heterozygous 979C-T transition in … (more)
In affected members of 2 unrelated families with autosomal dominant progressive external ophthalmoplegia-5 (PEOA5; 613077), Tyynismaa et al. (2009) identified a heterozygous 979C-T transition in the last exon of the RRM2B gene, resulting in an arg327-to-ter (R327X) substitution. The substitution was predicted to result in a protein lacking the last 25 amino acids. One family was North American of European origin, and the second was Hungarian. The mutation was not observed in 380 control European chromosomes, and there was no evidence of a founder effect. The phenotype was characterized by late-onset of mild ophthalmoplegia and mild muscle weakness. Skeletal muscle biopsies showed mtDNA deletions, but normal mtDNA copy numbers. RNA studies showed that the R328X mRNA escaped nonsense-mediated decay, and that the mutant protein was expressed and stable. The findings suggested that the mutant RRM2B protein can compete with wildtype in binding to ribonucleotide reductase, causing a dominant-negative or gain-of-function effect. (less)
|
|
not provided
(-)
|
no classification provided
Method: phenotyping only
|
Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5
Affected status: yes
Allele origin:
unknown
|
GenomeConnect, ClinGen
Accession: SCV001423177.1
First in ClinVar: Jul 19, 2020 Last updated: Jul 19, 2020 |
Comment:
Variant interpretted as Pathogenic and reported on 04-15-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided … (more)
Variant interpretted as Pathogenic and reported on 04-15-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. (less)
Clinical Features:
Abnormality of eye movement (present) , Abnormality of vision (present) , Myopia (disease) (present) , Hypermetropia (present) , Abnormal retinal morphology (present) , Tinnitus (present) … (more)
Abnormality of eye movement (present) , Abnormality of vision (present) , Myopia (disease) (present) , Hypermetropia (present) , Abnormal retinal morphology (present) , Tinnitus (present) , Memory impairment (present) , Depressivity (present) , Abnormality of muscle physiology (present) , Abnormality of the musculature of the limbs (present) , Abnormality of the musculature (present) , Abnormality of the musculature of the pelvis (present) , Abnormal pattern of respiration (present) , Abnormality of esophagus morphology (present) , Abnormality of the intestine (present) , Colon cancer (present) (less)
Indication for testing: Diagnostic
Age: 40-49 years
Sex: male
Method: Sanger Sequencing
Testing laboratory: GeneDx
Date variant was reported to submitter: 2019-04-15
Testing laboratory interpretation: Pathogenic
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
RRM2B-related mitochondrial disease
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV000153714.4
First in ClinVar: May 30, 2014 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
RRM2B Mitochondrial DNA Maintenance Defects. | Adam MP | - | 2021 | PMID: 24741716 |
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. | Pitceathly RD | Brain : a journal of neurology | 2012 | PMID: 23107649 |
A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. | Tyynismaa H | American journal of human genetics | 2009 | PMID: 19664747 |
Text-mined citations for rs121918310 ...
HelpRecord last updated Nov 19, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.